A story of two ACEs - PubMed (original) (raw)
Review
A story of two ACEs
Ursula Danilczyk et al. J Mol Med (Berl). 2003 Apr.
Abstract
According to the World Health Organization predictions cardiovascular diseases will be the leading cause of death by the year 2020. High blood pressure is a major risk factor for myocardial infarction, cerebrovascular disease, and stroke. Modulation of the renin-angiotensin system, particularly inhibition of the angiotensin-converting enzyme (ACE), has become a prime strategy in the treatment of hypertension and heart failure. Recently the gene of a new ACE, termed ACE2, has been characterized. The ACE2 gene maps to defined quantitative trait loci on the X chromosome in three different rat models of hypertension, suggesting ACE2 as a candidate gene for hypertension. In mice the targeted disruption of ACE2 resulted in increased systemic angiotensin II levels, impaired cardiac contractility, and upregulation of hypoxia-induced genes in the heart. Since mice deficient in both ACE2 and ACE show completely normal heart function, it appears that ACE and ACE2 negatively regulate each other. The mechanisms and physiological significance of the interplay between ACE and ACE2 are not yet elucidated, but it may involve several new peptides and peptide systems. In view of drug development the increasing complexity of the renin-angiotensin system offers both challenge and opportunity to develop new and refined treatment strategies against cardiovascular diseases.
Similar articles
- Angiotensin-converting enzyme 2 is an essential regulator of heart function.
Crackower MA, Sarao R, Oudit GY, Yagil C, Kozieradzki I, Scanga SE, Oliveira-dos-Santos AJ, da Costa J, Zhang L, Pei Y, Scholey J, Ferrario CM, Manoukian AS, Chappell MC, Backx PH, Yagil Y, Penninger JM. Crackower MA, et al. Nature. 2002 Jun 20;417(6891):822-8. doi: 10.1038/nature00786. Nature. 2002. PMID: 12075344 - The role of ACE2 in cardiovascular physiology.
Oudit GY, Crackower MA, Backx PH, Penninger JM. Oudit GY, et al. Trends Cardiovasc Med. 2003 Apr;13(3):93-101. doi: 10.1016/s1050-1738(02)00233-5. Trends Cardiovasc Med. 2003. PMID: 12691672 Review. - Myocardial infarction increases ACE2 expression in rat and humans.
Burrell LM, Risvanis J, Kubota E, Dean RG, MacDonald PS, Lu S, Tikellis C, Grant SL, Lew RA, Smith AI, Cooper ME, Johnston CI. Burrell LM, et al. Eur Heart J. 2005 Feb;26(4):369-75; discussion 322-4. doi: 10.1093/eurheartj/ehi114. Epub 2005 Jan 25. Eur Heart J. 2005. PMID: 15671045 - Angiotensin-converting enzyme II in the heart and the kidney.
Danilczyk U, Penninger JM. Danilczyk U, et al. Circ Res. 2006 Mar 3;98(4):463-71. doi: 10.1161/01.RES.0000205761.22353.5f. Circ Res. 2006. PMID: 16514079 Review. - Physiological roles of angiotensin-converting enzyme 2.
Danilczyk U, Eriksson U, Oudit GY, Penninger JM. Danilczyk U, et al. Cell Mol Life Sci. 2004 Nov;61(21):2714-9. doi: 10.1007/s00018-004-4241-6. Cell Mol Life Sci. 2004. PMID: 15549172 Review.
Cited by
- Protective neutralizing epitopes in SARS-CoV-2.
Liu H, Wilson IA. Liu H, et al. Immunol Rev. 2022 Sep;310(1):76-92. doi: 10.1111/imr.13084. Epub 2022 May 22. Immunol Rev. 2022. PMID: 35599305 Free PMC article. Review. - CD209L/L-SIGN and CD209/DC-SIGN Act as Receptors for SARS-CoV-2.
Amraei R, Yin W, Napoleon MA, Suder EL, Berrigan J, Zhao Q, Olejnik J, Chandler KB, Xia C, Feldman J, Hauser BM, Caradonna TM, Schmidt AG, Gummuluru S, Mühlberger E, Chitalia V, Costello CE, Rahimi N. Amraei R, et al. ACS Cent Sci. 2021 Jul 28;7(7):1156-1165. doi: 10.1021/acscentsci.0c01537. Epub 2021 Jun 30. ACS Cent Sci. 2021. PMID: 34341769 Free PMC article. - Dual role for angiotensin-converting enzyme 2 in Severe Acute Respiratory Syndrome Coronavirus 2 infection and cardiac fat.
Flinn B, Royce N, Gress T, Chowdhury N, Santanam N. Flinn B, et al. Obes Rev. 2021 May;22(5):e13225. doi: 10.1111/obr.13225. Epub 2021 Mar 3. Obes Rev. 2021. PMID: 33660398 Free PMC article. Review. - Increased placental expression of angiotensin-converting enzyme 2, the receptor of SARS-CoV-2, associated with hypoxia in twin anemia-polycythemia sequence (TAPS).
Mao Q, Chu S, Shapiro S, Bliss JM, De Paepe ME. Mao Q, et al. Placenta. 2021 Feb;105:7-13. doi: 10.1016/j.placenta.2021.01.008. Epub 2021 Jan 15. Placenta. 2021. PMID: 33497931 Free PMC article.
References
- Circ Res. 2002 Jan 11;90(1):87-92 - PubMed
- Pharmacol Rev. 1998 Sep;50(3):357-86 - PubMed
- Hypertension. 1995 Feb;25(2):170-3 - PubMed
- Physiol Rev. 1998 Oct;78(4):1055-85 - PubMed
- Kidney Int Suppl. 1998 Sep;67:S71-4 - PubMed
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Miscellaneous